Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Bridging Study to Evaluate the PK, Safety and Tolerability of SR419 in Healthy Subjects

NCT05012761 is registered in ClinicalTrials.gov with Shanghai SIMR Biotechnology Co., Ltd. as lead sponsor.

NCT NCT05012761
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05012761 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Bridging Study to Evaluate the PK, Safety and Tolerability of SR419 in Healthy Subjects
Lead sponsor
Shanghai SIMR Biotechnology Co., Ltd.
Phase
Phase 1
Overall status
Completed
Start date
August 24, 2021
Completion date
May 27, 2022
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy